Generating Evidence. Transforming Lives
We envision a healthy and empowered population with access to evidence-based health services and solutions.
We’ll strive to achieve this vision by transforming into a center of excellence that informs health policies and delivery of quality services collaboratively through research, innovation, capacity strengthening and program implementation.
About IHI
Ifakara Health Institute (IHI) is a leading health research organization in Africa, with a strong track record of developing, testing and validating innovations for health. We are driven by core strategic mandate for research, training and services. Ifakara encompasses a broad range of scientific disciplines, spanning from basic biomedical and ecological sciences to clinical trials, health systems research, policy translation, and health program implementation.
More from
Ifakara Health Institute
Data Repository
Our Data Repository serves as a centralized hub for all data-related resources, ensuring easy access and efficient management of our organization's valuable information.
Explore moreOur Projects
We have over sixty active projects.
Tracking health financing for universal health coverage in the era of shocks - "FINTRACK Project"
Ifakara Health Institute in collaboration with London School of Hygiene & Tropical Medicine (LSHTM) is set to conduct the Financing Tracking Analysis (FINTRACK) Project which aims to track health financing indicators in the context of shocks, such as the COV…
Impact of human pegivirus on natural immunity to malaria (PEMA)
Ifakara Health Institute is implementing the PEMA project, a two-year study designed to investigate how the human Pegivirus (HPgV) modulates Plasmodium infections, particularly in relation to different malaria outcomes and immune system responses. To achieve its obje…
Trial to evaluate multiple regimes, durations of treatment for TB - "PARADGM4TB"
Ifakara Health Institute is implementing a 5-year clinical trial project titled PARADGM4TB, aiming to revolutionize the treatment of pulmonary tuberculosis (TB). Sponsored by University College London (UCL), this study seeks to evaluate multiple drug regimens and tre…